Northside Hospital, Inc. - GCS/Center Pointe — Atlanta, Georgia

Northside Hospital, Inc. - GCS/Center Pointe is a clinical research site located in Atlanta, Georgia, United States 30342.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Northside Hospital, Inc. - GCS/Center Pointe has participated in 1 clinical trials.

Therapeutic areas: HER2 Positive Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Atlanta

Browse all research sites in Georgia · View every site in Atlanta

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northside Hospital, Inc. - GCS/Center Pointe?

Northside Hospital, Inc. - GCS/Center Pointe has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northside Hospital, Inc. - GCS/Center Pointe conducted?

Northside Hospital, Inc. - GCS/Center Pointe has 1 clinical trials on record. Their work covers HER2 Positive Breast Cancer.

Is Northside Hospital, Inc. - GCS/Center Pointe accredited by Crixeo Clinical Trials?

Northside Hospital, Inc. - GCS/Center Pointe has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northside Hospital, Inc. - GCS/Center Pointe?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.